ConductScience.org, home

Trial · NCT07891065

Registered outcomes22

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryEEG profilAt Baseline
The EEG characteristics will be described according to 3 categories: 1) spike-wave bursts (SWB) profile, 2) alteration of sleep spindles profile, 3) others profile. This assessment will be conducted in a blinded manner by 3 pediatric neurologists. The analysis will focus on the first 10 minutes of sleep, using a standardized assessment grid.
SecondaryStatus of patient exome regarding ASDBaseline
Exome results classified as pathogenic (Class 5) or likely pathogenic (Class 4) according to the recommendations of the American College of Medical Genetics and Genomics (ACMG) will be considered "positive". Others will be considered "negative"
SecondaryNumber of spike-wave bursts (SWB) on EEGBaseline
SecondaryDuration of spike-wave bursts (SWB) on EEGBaselineIn seconds
SecondaryLocation of spike-wave bursts (SWB) on EEGAt BaselineClassified as frontal, bifrontal, diffuse, or focal
SecondaryNumber of sleep spindles (SWB) on EEGBaseline
SecondaryAmplitude of sleep spindles (SWB) on EEG, rated on a 3-point scaleBaseline
SecondaryFrequency of sleep spindles (SWB) on EEGBaselineClassified as alpha or beta
SecondaryDuration of sleep spindles (SWB) on EEGBaselineIn seconds
SecondarySpindle synchrony on EEGBaselineClassified as synchronous or asynchronous
SecondaryBackground rhythm in the awake state on EEGBaselineClassified as alpha, theta, beta, or gamma
SecondaryPatient ageBaselineIn years
SecondaryPatient genderBaselinemale/female
SecondaryFamilial history of ASDBaselineYes/No
SecondarySocio-economic status of the parentsBaselineFarmers /Artisans, Merchants, Business Owners / Managers and Professionals Intermediate Occupations / Office Workers / Manual Laborers
SecondarySeverity of ASD according to DSM VBaselineMinor / moderate / major
SecondaryNature of ASDBaselineRegressive (Yes/No) or non-regressive (Yes/no)
SecondaryPresence or absent of associated signsBaselineFacial dysmorphia (Yes/No), heart disease (Yes/No), limb abnormalities (Yes/No), epilepsy (Yes/No)
SecondaryPresent or absent of neurological examination abnormalitiesBaselineCebellar syndrome (Yes/No), pyramidal syndrome (Yes/No), nystagmus (Yes/No), abnormal ROT (Yes/No), strabismus (Yes/No)
SecondaryDegree of language delayBaselineNone, light, moderate, severe

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07891065/registered